Recently Viewed

      Listening...
      Home / Our Company / Discover J&J /
      Corporate reports

      Corporate reports

      Here are some of the print and digital publications we produce each year that recap the company’s business performance and key enterprise-wide milestones.

      Annual meeting materials
      Man looking at samples in a large lab

      2022 Health for Humanity Report

      Explore past issues of the Health for Humanity Report dating back to 2017.
      Read the reports

      More from Johnson & Johnson

      Innovation
      Managing dermatomyositis, a rare autoimmune disease causing muscle weakness
      May 3, 2024

      “I couldn’t speak, walk or sit.” Inside a rare autoimmune disease that attacks the muscles

      Elisa Glass was diagnosed with dermatomyositis, which causes severe muscle weakness throughout the body. For Myositis Awareness Month, she shares her story.
      Read more
      Health & wellness
      Illustration of three human bladders representing bladder cancer
      April 30, 2024

      5 things we now know about bladder cancer

      Paradigm-shifting new therapies are helping people with the disease lead longer, more comfortable lives. For Bladder Cancer Awareness Month, learn how Johnson & Johnson is helping to change the treatment landscape.
      Read more
      Innovation
      IL-23 protein structures
      April 29, 2024

      What is IL-23?

      This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
      Read more
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
      Continue